Carlsmed (CARL) vs Claritev (CTEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Carlsmed (CARL) has outperformed Claritev (CTEV) over the past year, gaining 1.7% versus a loss of 57.6%. Claritev is the larger company by market cap ($412.3 million vs $383.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CARL | CTEV |
|---|---|---|
| Share price | $14.05 | $24.33 |
| Market cap | $383.60M | $412.33M |
| 1-day change | -2.29% | -2.80% |
| YTD return | +13.77% | -43.09% |
| 1-year return | +1.66% | -57.58% |
| 5-year return | — | -86.51% |
| Forward P/E | — | 3.32 |
| EPS (TTM) | $-1.08 | $-17.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.23 | $73.68 |
| 52-week low | $8.50 | $11.50 |
| Distance from 52-week high | -18.46% | -66.98% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +36.65% | +89.07% |
| Average volume | 125.43K | 135.83K |
| Shares outstanding | 27.30M | 16.95M |
| Employees | 127 | 3,000 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Medical/Dental Instruments | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CARL has outperformed CTEV by 59.2 percentage points over the past year.
- The two companies sit in different sectors: Carlsmed in Health Care and Claritev in Consumer Discretionary.
About Carlsmed
CARL stock →Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Health Care · Medical/Dental Instruments · 127 employees
About Claritev
CTEV stock →Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
Consumer Discretionary · Business Services · 3,000 employees
CARL vs CTEV FAQ
Which is bigger, Carlsmed or Claritev?
Claritev (CTEV) is larger, with a market capitalization of $412.33M compared with $383.60M for Carlsmed (CARL).
Which stock has performed better over the past year, CARL or CTEV?
CARL returned +1.66% over the past 12 months, compared with -57.58% for CTEV (price return, excluding dividends). Past performance does not predict future results.
Are Carlsmed and Claritev in the same industry?
No. Carlsmed is in the Health Care sector, while Claritev is in Consumer Discretionary.